BERNARDI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 157.431
AS - Asia 16.002
EU - Europa 12.475
SA - Sud America 1.992
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 28
AN - Antartide 1
Totale 188.141
Nazione #
US - Stati Uniti d'America 157.135
SG - Singapore 8.857
CN - Cina 3.128
UA - Ucraina 2.426
DE - Germania 2.141
RU - Federazione Russa 1.666
BR - Brasile 1.654
HK - Hong Kong 1.487
IE - Irlanda 1.292
FR - Francia 1.034
VN - Vietnam 952
IT - Italia 869
SE - Svezia 761
GB - Regno Unito 630
PL - Polonia 624
FI - Finlandia 595
KR - Corea 479
JP - Giappone 351
IN - India 156
CA - Canada 150
AR - Argentina 132
BD - Bangladesh 98
NL - Olanda 97
MX - Messico 81
BE - Belgio 71
ID - Indonesia 66
IQ - Iraq 56
TR - Turchia 55
ES - Italia 54
EU - Europa 51
EC - Ecuador 50
ZA - Sudafrica 50
AT - Austria 43
VE - Venezuela 35
UZ - Uzbekistan 34
KG - Kirghizistan 33
PK - Pakistan 33
CL - Cile 31
CO - Colombia 29
CZ - Repubblica Ceca 29
MA - Marocco 28
AU - Australia 25
SA - Arabia Saudita 25
PY - Paraguay 22
PH - Filippine 21
IL - Israele 20
RO - Romania 19
CH - Svizzera 18
EG - Egitto 18
LT - Lituania 18
UY - Uruguay 16
KE - Kenya 15
PE - Perù 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
MY - Malesia 14
IR - Iran 13
JO - Giordania 13
HN - Honduras 12
AZ - Azerbaigian 11
GR - Grecia 11
KZ - Kazakistan 11
NP - Nepal 11
TT - Trinidad e Tobago 11
AL - Albania 10
BG - Bulgaria 10
OM - Oman 10
DM - Dominica 9
GE - Georgia 9
PT - Portogallo 9
DK - Danimarca 8
CR - Costa Rica 7
DZ - Algeria 7
JM - Giamaica 7
TH - Thailandia 7
BH - Bahrain 6
LB - Libano 6
RS - Serbia 6
DO - Repubblica Dominicana 5
HR - Croazia 5
LV - Lettonia 5
MT - Malta 5
NG - Nigeria 5
NI - Nicaragua 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
CI - Costa d'Avorio 4
KH - Cambogia 4
CG - Congo 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
Totale 188.102
Città #
Woodbridge 49.573
Wilmington 39.407
Houston 36.528
Fairfield 4.888
Ann Arbor 4.138
Singapore 3.369
Ashburn 2.488
Jacksonville 2.244
Seattle 1.978
Cambridge 1.614
Hong Kong 1.473
Chandler 1.394
San Jose 1.386
Dublin 1.291
Beijing 1.049
Medford 976
Dearborn 601
Kraków 576
Santa Clara 565
The Dalles 523
Lawrence 464
New York 459
Zhengzhou 368
Mülheim 349
Los Angeles 331
Ho Chi Minh City 307
Tokyo 276
Buffalo 268
Moscow 268
Hangzhou 264
San Diego 237
Menlo Park 223
Hanoi 221
Rome 171
Lauterbourg 167
Council Bluffs 150
Dallas 145
Milan 144
São Paulo 143
Falls Church 131
Munich 115
Helsinki 109
University Park 103
Mountain View 100
London 97
San Mateo 96
Shanghai 96
Chicago 92
Verona 88
Norwalk 83
Orem 82
Detroit 80
Guangzhou 78
Hefei 74
Redwood City 71
Mcallen 64
Boardman 63
Brussels 58
Palo Alto 58
Nanjing 55
Rio de Janeiro 54
Brooklyn 49
Redondo Beach 48
Saint Petersburg 48
Chennai 47
Montreal 46
Toronto 41
Atlanta 40
Nuremberg 40
Brasília 39
Frankfurt am Main 39
Phoenix 38
Warsaw 38
Da Nang 37
Haiphong 37
Nürnberg 36
San Francisco 35
Dhaka 34
Stockholm 34
Kunming 33
Belo Horizonte 32
Columbus 32
Denver 32
Jakarta 31
Johannesburg 31
Porto Alegre 30
Amsterdam 28
North Bergen 28
Boston 27
Campinas 25
Mexico City 24
Brno 23
Manchester 23
Tashkent 23
Curitiba 22
Jinan 22
Biên Hòa 21
St Louis 21
Turku 21
Redmond 20
Totale 164.138
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 724
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 615
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 610
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 607
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
TRPV1 channels facilitate glutamate transmission in the striatum 596
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 574
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 570
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 567
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 564
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder 556
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 549
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 547
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 542
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 537
Leukocyte aggregation in patients with a previous cerebral ischemic event 529
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 527
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 518
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 517
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 513
Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis 511
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 511
Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-Tooth disease type 1A 509
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 506
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 506
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro 504
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 503
The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles 501
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 497
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 497
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation 496
Video-assisted completion thymectomy in refractory myasthenia gravis 492
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 492
Clinical and genetic study of a large SPG4 Italian family 491
Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons 490
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 487
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 487
Serial determinations of leukocyte aggregation in patients with ischemic stroke 485
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 484
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 481
Up-regulation of P2X(2), P2X(4) receptor and ischemic cell death: Prevention by P2 antagonists 480
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 480
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 480
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 480
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 479
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment 478
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 477
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 477
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 473
Muscarinic IPSPs in rat striatal cholinergic interneurones 472
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 472
Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study 471
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 471
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 470
Thoracoscopic thymectomy in autoimmune myasthenia: Results of left-sided approach 469
Left thoracoscopic approach to the thymus in myasthenic patients 469
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 469
Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor 468
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy 468
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 467
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 466
Sural nerve without nerve fibers in leprous neuropathy 466
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 466
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 465
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 465
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture 465
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 464
Distinct roles of group I mGlu receptors in striatal function 464
Distinguishing forms of generalized epilepsy using magnetic brain stimulation 463
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 463
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 463
Serial determinations of leukocyte aggregation in patients with ischemic stroke 463
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 463
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat 463
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 463
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 463
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 462
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 462
Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia 462
TRPV1 channels regulate cortical excitability in humans 462
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 461
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 460
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 460
The Blockade of K+-ATP channels has neuroprotective effects in an in vitro model of brain ischemia 460
Altered vulnerability to kainate excitotoxicity of transgenic-Cu/Zn SOD1 neurones 459
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 459
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 459
Migraine-like disorder segregating with mtDNA 14484 Leber hereditary optic neuropathy mutation 458
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 456
Bilateral simultaneous transcranial Doppler monitoring of flow velocity changes during visuospatial and verbal working memory tasks 456
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 456
Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue 455
Video-assisted complete thymectomy in the treatment of autoimmune myasthenia [Timectomia estesa video-assistita nel trattamento della miastenia autoimmune] 455
Synaptic transmission in the striatum: from plasticity to neurodegeneration 455
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 455
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 455
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 454
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 454
Early subclinical cochlear dysfunction in myotonic dystrophy type 1. 454
Dystrophin is not essential for the integrity of the cytoskeleton 453
Totale 49.175
Categoria #
all - tutte 383.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 383.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.314 0 0 0 0 0 0 0 0 0 0 1.000 314
2021/20224.433 134 476 189 251 139 549 213 193 287 475 192 1.335
2022/20234.612 564 284 99 497 322 1.282 418 218 354 13 454 107
2023/20241.293 140 45 109 27 113 378 60 89 19 17 13 283
2024/202511.886 306 2.422 1.129 530 216 654 669 365 824 611 2.365 1.795
2025/202613.404 1.121 827 1.796 1.135 1.220 517 1.572 1.968 1.671 1.481 96 0
Totale 188.795